Black Swan Analysis appoints Luke McDermott
pharmafile | February 28, 2011 | Appointment | Sales and Marketing |Â Â Black Swan Analysis, Luke McDermott, appointment, sales and marketingÂ
Maidenhead, UK-based Black Swan Analysis has expanded its analysis and forecasting team with the appointment of Luke McDermott.
He joins the company as a business analyst and brings with him a strong scientific and business background following the completion of an MSc from the University of Warwick.
Related Content
David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.
Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …
Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …
